368 results on '"Coupé, Veerle M. H."'
Search Results
52. Model_validation(SSL)_Appendix_online_supp – Supplemental material for Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials
53. Cost-Effectiveness of Surveillance Scanning Strategies after Curative Treatment of Non–Small-Cell Lung Cancer
54. Choosing a Metamodel of a Simulation Model for Uncertainty Quantification.
55. Definition of competence standards for optical diagnosis of diminutive colorectal polyps: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
56. Methodological framework for development of competence standards for optical diagnosis in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
57. Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials
58. Model-based evaluation of the cost effectiveness of 3versus6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients
59. Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers.
60. The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee
61. Sensitivity Analysis for Threshold Decision Making with Bayesian Belief Networks
62. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia
63. Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer
64. Cost-Effectiveness of Surveillance Scanning Strategies after Curative Treatment of Non–Small-Cell Lung Cancer.
65. Estimating Population-Based Recurrence Rates of Colorectal Cancer over Time in the United States.
66. Model-based evaluation of the cost effectiveness of 3 versus 6 months' adjuvant chemotherapy in high-risk stage II colon cancer patients.
67. Cost-effectiveness of different strategies for diagnosis of uncomplicated urinary tract infections in women presenting in primary care
68. Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?
69. Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis
70. Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.
71. Effectiveness, cost-utility and implementation of a decision aid for patients with localised prostate cancer and their partners: study protocol of a stepped-wedge cluster randomised controlled trial
72. Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial
73. Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study
74. Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia.
75. Resilience of a FIT screening programme against screening fatigue: a modelling study
76. Effectiveness and cost-utility of a guided self-help exercise program for patients treated with total laryngectomy: protocol of a multi-center randomized controlled trial
77. The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis
78. Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis
79. The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
80. Cost-utility analysis of meaning-centered group psychotherapy for cancer survivors.
81. Clinical Usefulness of Tools to Support Decision-making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic Review.
82. Size and shape of the associations of glucose, HbA, insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study.
83. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case–Control Study.
84. MODEL-BASED COST-EFFECTIVENESS OF CONVENTIONAL AND INNOVATIVE CHEMO-RADIATION IN LUNG CANCER.
85. Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial.
86. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
87. Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.
88. Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F-FDG-PET-CT and/or diffusion-weighted MRI.
89. Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.
90. Modeling the Adenoma and Serrated Pathway to Colorectal CAncer (ASCCA)
91. Abstract 1151: Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.
92. Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality--Model-Based Exploration of the Serrated Pathway.
93. Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
94. Economic evaluations of diagnostic tests, treatment and prevention for lateral ankle sprains: a systematic review
95. The cost effectiveness of elective laparoscopic sigmoid resection for symptomatic diverticular disease: financial outcome of the randomized control Sigma trial
96. Incidence of enteropathy - associated T-cell lymphoma: A nation-wide study of a population-based registry in The Netherlands
97. Individualized positron emission tomography-based isotoxic accelerated radiation therapy is cost-effective compared with conventional radiation therapy: a model-based evaluation.
98. Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
99. Sensitivity analysis: an aid for belief-network quantification
100. Comorbidity of anxiety and depressive disorders: A comparative population study in Western and non-Western inhabitants in the Netherlands.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.